[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3776269D1 - Labetalol tablette mit verzoegerter wirkstoffabgabe. - Google Patents

Labetalol tablette mit verzoegerter wirkstoffabgabe.

Info

Publication number
DE3776269D1
DE3776269D1 DE8787116021T DE3776269T DE3776269D1 DE 3776269 D1 DE3776269 D1 DE 3776269D1 DE 8787116021 T DE8787116021 T DE 8787116021T DE 3776269 T DE3776269 T DE 3776269T DE 3776269 D1 DE3776269 D1 DE 3776269D1
Authority
DE
Germany
Prior art keywords
labetalol
tablet
active substances
delayed delivery
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787116021T
Other languages
English (en)
Inventor
Surendra Sangekar
Winston A Vadino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of DE3776269D1 publication Critical patent/DE3776269D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787116021T 1986-11-03 1987-10-31 Labetalol tablette mit verzoegerter wirkstoffabgabe. Expired - Lifetime DE3776269D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92630686A 1986-11-03 1986-11-03

Publications (1)

Publication Number Publication Date
DE3776269D1 true DE3776269D1 (de) 1992-03-05

Family

ID=25453030

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787116021T Expired - Lifetime DE3776269D1 (de) 1986-11-03 1987-10-31 Labetalol tablette mit verzoegerter wirkstoffabgabe.

Country Status (5)

Country Link
EP (1) EP0266707B1 (de)
JP (1) JPS63126825A (de)
AT (1) ATE71833T1 (de)
DE (1) DE3776269D1 (de)
GR (1) GR3003745T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2723919B2 (ja) * 1988-09-02 1998-03-09 エーザイ株式会社 環状アミン誘導体を含有する経口用医薬品組成物
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
DE4001622A1 (de) * 1990-01-20 1991-07-25 Thomae Gmbh Dr K Orale arzneimittelformen von pimobendan
SK281042B6 (sk) 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Prípravok hydrogélového typu s ustáleným uvoľňovaním
JP3598049B2 (ja) * 1992-09-18 2004-12-08 山之内製薬株式会社 ハイドロゲル徐放性製剤
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
CN117045610B (zh) * 2023-08-24 2024-04-30 杭州沐源生物医药科技有限公司 一种溶出高稳定性的盐酸拉贝洛尔组合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012444A (en) * 1969-07-08 1977-03-15 Allen & Hanburys Limited 5-[1-Hydroxy-2-(1-methyl-3-phenylpropyl)aminoethyl] salicylamide and physiologically acceptable acid addition salts thereof
GB1555958A (en) * 1976-02-27 1979-11-14 Allen & Hanburys Ltd Amino hydroxyethyl salicylamides processes for their preparation and compositions containing them
GB2181053B (en) * 1985-10-01 1990-05-23 Sandoz Ltd Pharmaceutical formulations with controlled release of the active substance
FR2588188B1 (fr) * 1985-10-04 1988-01-08 Delalande Sa Comprime de sel(s) hydrosoluble(s) de cinepazide a liberation programmee et son procede de preparation

Also Published As

Publication number Publication date
ATE71833T1 (de) 1992-02-15
EP0266707A3 (en) 1989-05-03
EP0266707A2 (de) 1988-05-11
JPS63126825A (ja) 1988-05-30
GR3003745T3 (de) 1993-03-16
EP0266707B1 (de) 1992-01-22

Similar Documents

Publication Publication Date Title
HK1010447A1 (en) Tramadol salt containing medicaments with sustained release of the active ingredient
ATE78157T1 (de) Arzneimittel mit langsamer freisetzung.
DE3778781D1 (de) Antiphlogistika enthaltende pharmazeutische formulierungen mit gesteuerter freigabe.
DE3681582D1 (de) Pharmazeutische zubereitung mit abgabeeigenschaften.
DE3868037D1 (de) Pharmazeutische zusammensetzung mit verzoegerter wirkstoffabgabe.
DE69206345D1 (de) Arzneimittel zur intranasalen Verabreichung, die Ketorolac R enthalten.
RU93036959A (ru) Свободно растворимый лекарственный препарат с замедленным действием биологически активных веществ, назначенный для приема внутрь, способ его производства
DE3875108D1 (de) Physiologisch aktives polypeptid und pharmazeutische komposition.
ITMI913170A0 (it) Composizione farmaceutica per uso oftalmico contenente un antinfiammatorio non steroideo ed un decongestionante come principi attivi
DE3776269D1 (de) Labetalol tablette mit verzoegerter wirkstoffabgabe.
RU98111152A (ru) Применение активного вещества флупиртина или его фармакологически приемлемых солей в качестве лекарственного средства для профилактики и лечения заболеваний, ассоциированных с повреждением клеточной системы гемопоэза
IT8622082A0 (it) Preparato farmaceutico a base di buflomedil cloridrato, sotto formadi compresse a rilascio controllato e relativo procedimento di preparazione.
ATE15139T1 (de) Phosphonomycine pharmazeutische zusammensetzung in tablettenform.
ITBO930294A0 (it) Procedimento per preparare forme farmaceutiche a rilascio controllato/ritardato del principio attivo e le forme farmaceutiche cosi' ottenute
DK493887A (da) Buccal formulering
ES2082524T3 (es) Medicamento de liberacion retardada que contiene un derivado de dihidropiridina en forma de nanosol y su preparacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee